Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,489
datasets available to search
ShareScore release 0.9.0
Dataset results
2,489 results for “Sars-CoV-2”
LSALT Peptide vs. Placebo to Prevent ARDS and Acute Kidney Injury in Patients Infected With SARS-CoV-2 (COVID-19)
ClinicalTrials.gov study NCT04402957. IPD Sharing: UNDECIDED. Countries: 3. Publications: 1.
VERU-111 in the Treatment of SARS-Cov-2 Infection by Assessing Its Effect on the Proportion of Patients Who Die on Study
ClinicalTrials.gov study NCT04842747. IPD Sharing: NO. Countries: 6. Publications: 1.
Serological Response to SARS-Cov-2 Virus in Personnel of the Institut Bergonié in the Context of the COVID-19 Pandemic
ClinicalTrials.gov study NCT04426006. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study of Activity Leader to Forest Therapy Campaign in Different Environments Targets on the Participants Which Had Been Infected by SARS-COV-2
ClinicalTrials.gov study NCT06601920. IPD Sharing: UNDECIDED. Countries: 1. Publications: 11.
A Study of mRNA-based Influenza and SARS-CoV-2 (COVID-19) Multi-component Vaccines in Healthy Adults
ClinicalTrials.gov study NCT05827926. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety and Immunogenicity Study of a SARS-CoV-2 (COVID-19) Variant Vaccine (mRNA-1273.351) in Naïve and Previously Vaccinated Adults
ClinicalTrials.gov study NCT04785144. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Ventilator-induced Lung Injury Vortex in Patients With SARS-CoV-2
ClinicalTrials.gov study NCT04174313. IPD Sharing: NO. Countries: 1. Publications: 5.
REassessement After Hospitalization for Sars-COV-2 disordER
ClinicalTrials.gov study NCT04443257. IPD Sharing: YES. Countries: 1. Publications: 1.
Seroprevalence of SARS-Cov-2 Antibodies in Children
ClinicalTrials.gov study NCT04347408. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Human Convalescent Plasma for High Risk Children Exposed or Infected With SARS-CoV-2 (COVID-19)
ClinicalTrials.gov study NCT04377672. IPD Sharing: NO. Countries: 1. Publications: 2.
A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-Mediated COVID-19 in Adult Participants
ClinicalTrials.gov study NCT04505722. IPD Sharing: YES. Countries: 8. Publications: 8.
Live Microbials to Boost Anti-Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Immunity Clinical Trial
ClinicalTrials.gov study NCT04847349. IPD Sharing: YES. Countries: 1. Publications: 1.
A Study to Evaluate the Safety and Efficacy of C19-IG 20% in SARS-CoV-2 Infected Asymptomatic Ambulatory Outpatients
ClinicalTrials.gov study NCT04847141. IPD Sharing: NO. Countries: 1. Publications: 1.
Antiseptic Mouthwash / Pre-Procedural Rinse on SARS-CoV-2 Load (COVID-19)
ClinicalTrials.gov study NCT04409873. IPD Sharing: NO. Countries: 1. Publications: 14.
Creating a Sustainable Infrastructure for SARS-CoV-2 Testing (COVID-19) at Syringe Exchange Programs
ClinicalTrials.gov study NCT04852848. IPD Sharing: YES. Countries: 1. Publications: 1.
COVID-19 MP Biomedicals SARS-CoV-2 Ag OTC: Clinical Evaluation
ClinicalTrials.gov study NCT05584176. IPD Sharing: NO. Countries: 1. Publications: 3.
SARS-COV-2 Screening in Dialysis Facilities
ClinicalTrials.gov study NCT05225298. IPD Sharing: YES. Countries: 1. Publications: 2.
Endocrine, Metabolic and Microbiome Influence on the Post-acute Sequelae SARS-CoV-2 (PASC)
ClinicalTrials.gov study NCT04860869. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study to Evaluate the Immunogenicity and Safety of mRNA Vaccine Boosters for SARS-CoV-2 (COVID-19) Variants
ClinicalTrials.gov study NCT04927065. IPD Sharing: Not stated. Countries: 1. Publications: 3.
A Phase 2b/3, Randomized, Observer-Blinded, Placebo-Controlled, Multicenter Clinical Study Evaluating the Efficacy and Safety of Investigational SARS-CoV-2 mRNA Vaccine CVnCoV in Adults 18 Years of Ag
ClinicalTrials.gov study NCT04652102. IPD Sharing: Not stated. Countries: 10. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.